CD8A and neoplasm: on human blood-derived lymphocytes also suggest that in the context of tumor immunology, B cells have the ability to operate as efficient APCs, driving the expansion of both memory and naive tumor-associated antigen-specific CD4+ and CD8+ T cells96 (Fig. 2).